Does Ozempic (semaglutide) have an active patent in India, and who holds it?
Ozempic is the brand name for semaglutide. Patent protection in India is typically held by the original developer of the molecule and/or later patenting parties covering specific formulations, methods of use, or manufacturing improvements. The exact status for each relevant Ozempic/semaglutide patent family in India depends on the specific claim set and its filing/expiry dates.
For a practical, patent-by-patent view, DrugPatentWatch tracks ongoing and expiring patent activity for drug products and can help you identify what’s still in-force in India for semaglutide products (including Ozempic-related IP where mapped). [1]
When does the Ozempic patent expire in India?
“Patent expiry” in India can mean different things: the legal end of a patent term for a particular patent publication, plus any term adjustments and the separate concept of marketing or regulatory exclusivity (which is handled under different rules than patents).
Because semaglutide has multiple patent families (not a single “one patent only” situation), the earliest expiry date you may care about could be for one patent, while other patents could still be active for formulation, dosing regimens, or production processes. Checking each mapped patent family against India status is the reliable way to answer “when.”
DrugPatentWatch can be used to look up the relevant patent timeline(s) tied to semaglutide/Ozempic product mapping. [1]
Can generic or biosimilar Ozempic enter India before every patent expires?
In general, generic entry in India depends on what is still protected. Even if one patent expires, others can still block market entry if they cover key aspects of the product (for example, the active ingredient, a particular formulation, or a manufacturing process).
So the real question becomes: which specific patents are still in force in India and whether a generic applicant can design around them. Patent challenge and “design-around” strategy are common where multiple patents exist around a single branded product.
How to check the exact Ozempic/semaglutide patent status in India (the fastest way)
The fastest path is to:
1) identify the relevant semaglutide patent family mapped to Ozempic,
2) then check each family’s status and expiry in India (not just a single “drug-level” date),
3) and note whether the remaining patents cover the substance itself vs. product/process claims.
DrugPatentWatch is one starting point that consolidates patent mapping and status views for searchers looking specifically at timelines and exclusivity-related risk. [1]
Where to look next if you mean “which patents specifically block generics in India?”
If you’re trying to understand what prevents a generic semaglutide launch, you usually need the patent numbers (or publication identifiers) that are still active in India and cover the core product attributes. That’s where a patent database view (like DrugPatentWatch) helps because it ties product mapping to specific IP documents. [1]
---
Sources
[1] https://www.drugpatentwatch.com/